Diebold Nixdorf Incorporated (NYSE: DBD): The Best-Of-Breed For Investing?

0
105

Miller Value Partners LLC recently announced the acquisition of new stake in Diebold Nixdorf Incorporated (NYSE:DBD). The institutional investor has increased its shareholding in the Technology company by 1,158.07% to 2.92 million shares with purchase of 2.69 million shares. This fresh investment now brings its stake to 3.76% valued currently at $17.69 million. In addition, Sapience Investments LLC raised its holdings by 0.23 million to 2.87 million shares. And SSgA Funds Management, Inc. has lifted its position by 2.82% or 64635.0 shares – to 2.36 million shares.

With over 0.62 million Diebold Nixdorf Incorporated (DBD) shares trading Friday and a closing price of $6.11 on the day, the dollar volume was approximately $3.76 million. The shares have shown a positive weekly performance of 2.52% and its price on 07/24/20 lost nearly -3.78%. Currently, there are 77.20M common shares owned by the public and among those 75.27M shares have been available to trade.

An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 4 analysts who have offered their price forecasts for DBD have a consensus price objective of $11.33. The analysts have set the share’s price value over the next 12 months at a high of $13.00 and a low of $9.00 should the stock experience a downside. Incidentally, analysts’ outlook for the Diebold Nixdorf Incorporated stock is 2.20 for the next 12 months. But an upside of 53.0% will see the stock hit the forecast high price target while mean target price for the stock is $12.00.

Insiders at the company have transacted a total of 91 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 68 of these insider trades were purchases, accounting for 956,875 shares. Insider sales of the common stock occurred on 23 occasions, with total insider shares sold totaling 219,375 shares.

The top 3 mutual fund holders in Diebold Nixdorf Incorporated are iShares Core S&P Small Cap ETF, Vanguard Total Stock Market Index, and 1290 VT GAMCO Small Company Value. iShares Core S&P Small Cap ETF owns 4.78 million shares of the company’s stock, all valued at over $28.94 million. 1290 VT GAMCO Small Company Value sold 8000.0 shares to bring its total holdings to over 1.67 million shares at a value of $10.12 million. 1290 VT GAMCO Small Company Value now owns shares totaling to 2.15% of the shares outstanding.

Shares of Diebold Nixdorf Incorporated (NYSE: DBD) opened at $6.26, down -$0.09 from a prior closing price of $6.35. However, the script later closed the day at $6.11, down -3.78%. The company’s stock has a 5-day price change of 2.52% and 71.15% over the past three months. DBD shares are trading -42.14% year to date (YTD), with the 12-month market performance down to -53.61% lower. It has a 12-month low price of $2.80 and touched a high of $14.66 over the same period. Currently, 0.62 million shares have been traded, compared to an average intraday trading volume of 1.52 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.89%, 7.04%, and -15.71% respectively.

Institutional ownership of Diebold Nixdorf Incorporated (NYSE: DBD) shares accounts for 90.10% of the company’s 77.20M shares outstanding. Mutual fund holders own 47.54%, while other institutional holders and individual stakeholders account for 6.73% and 42.35% respectively.

It has a market capitalization of $520.57M and a beta (3y monthly) value of 3.18. The earnings-per-share (ttm) stands at -$3.92. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.90% over the week and 7.57% over the month.

Analysts forecast that Diebold Nixdorf Incorporated (DBD) will achieve an EPS of $0.01 for the current quarter, $0.1 for the next quarter and $1.42 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.04 while analysts give the company a high EPS estimate of $0.09. Comparatively, EPS for the current quarter was $0.06 a year ago. Earnings per share for the fiscal year are expected to increase by 37.20%, and 584.54% over the next financial year. EPS should grow at an annualized rate of 3.00% over the next five years, compared to -36.70% over the past 5-year period.

If you are looking to buy this stock, then you may note that the average analyst recommendation by 4 brokerage firm advisors rate Diebold Nixdorf Incorporated (DBD) as a “Moderate Buy” at a consensus score of 2.20. Specifically, 2 Wall Street analysts polled rate the stock as a buy, while 2 of the 4 advise that investors “hold,” and 0 rated it as a “Sell.”

Looking at the support for the DBD, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on May 11, 2020, with the firm’s price target at $6-$7. JP Morgan coverage for the Diebold Nixdorf Incorporated (DBD) stock in a research note released on March 27, 2020 offered a Underweight rating with a price target of $6. JP Morgan was of a view on November 01, 2019 that the stock is Neutral, while Sidoti gave the stock Buy rating on September 17, 2019, issuing a price target of . DA Davidson on their part issued Buy rating on January 09, 2019.

LEAVE A REPLY

Please enter your comment!
Please enter your name here